Fundz
Following MEDiC Life Sciences?

Get the free weekly contract digest

The latest new contracts, like MEDiC Life Sciences’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

MEDiC Life Sciences Collaborates with Hanmi Pharmaceutical on Cancer Biomarker Discovery

Oct 14, 2024•over 1 year ago

Contract Type

partnership

Mountain ViewBiotechnology

Description

MEDiC Life Sciences has announced a partnership with Hanmi Pharmaceutical for cancer biomarker discovery. The collaboration involves the use of MEDiC's MCAT™ platform to identify synthetic lethal biomarkers for Hanmi’s clinical assets, aiming to advance effective treatments for cancer patients.

Company Information

Company

MEDiC Life Sciences

Location

Mountain View, California, United States

About

MEDiC Life Sciences uses its MCAT™ platform to discover new therapeutic targets and biomarkers for solid cancers. In addition to developing its own drug programs, the company delivers novel targets and biomarkers for solid tumor indications being pursued by its partners' oncology programs. Founded in 2020, MEDiC emerged from discoveries made through Stanford University's SPARK program. MEDiC is backed by a group of financial and strategic investors, including LG, Hanmi Pharmaceutical, Top Harvest Capital, Primer Sazze Partners, Illumina Accelerator, Big Basin Capital, First In Ventures, and Wing Venture Capital.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for MEDiC Life Sciences's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.